Skip to main content
Mark Jackson, MD, Cardiology, Peoria, IL

MarkDJacksonMD

Cardiology Peoria, IL

Adult Congenital Heart Disease

Physician

Are you Dr. Jackson?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 67 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    5405 N Knoxville Ave
    Peoria, IL 61614
    Phone+1 309-691-4410
    Fax+1 309-589-2830

Summary

  • Dr. Mark Jackson, MD is a cardiologist in Peoria, Illinois. He is currently licensed to practice medicine in Illinois, Minnesota, and Iowa. He is affiliated with Carle Health Proctor Hospital, OSF Saint Francis Medical Center, and Carle Health Methodist Hospital.

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Cardiovascular Disease, 1988 - 1991
  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1985 - 1988
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1985

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1991 - 2023
  • IA State Medical License
    IA State Medical License 1985 - 2002
  • MN State Medical License
    MN State Medical License 1988 - 1991
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Fellow (FACC) American College of Cardiology

Press Mentions

  • Paras Biopharmaceuticals Successfully Develops Cytofold StructQuant® Technology for Cytoplasmic Disulphide Formation, (For Active Folding) for Complex Therapeutic Proteins
    Paras Biopharmaceuticals Successfully Develops Cytofold StructQuant® Technology for Cytoplasmic Disulphide Formation, (For Active Folding) for Complex Therapeutic ProteinsSeptember 10th, 2019
  • Reuters to Make Documentary on Paras Biopharmaceuticals Finland Oy – Innovations in Biologics: Insights of a Leading Expert
    Reuters to Make Documentary on Paras Biopharmaceuticals Finland Oy – Innovations in Biologics: Insights of a Leading ExpertMay 7th, 2019

Professional Memberships